Stevanato Group S.p.A. STVN
Set alert
19.38 USD -0.86 -4.25%
At close · Oct 30
19.38 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
19.08 Day range 20.80
13.43 52-week range 25.22
- YTD
- -3.68%
- 1 year
- -22.29%
- Open
- 20.51
- Prev close
- 20.24
- Mkt cap
- 5.29B
- Vol
- 557.66K
- Avg vol
- 388.97K
- EPS
- 0.57
- P/E
- 34.00
- Div yield
- 0.30%
More statistics
- Low
- 19.08
- High
- 20.80
- Forward P/E
- 23.42
- Beta
- 0.78
- Short ratio
- 3.04
- Inst. own
- 102.95%
- Dividend
- 0.06
- Ex-div date
- Jun 10, 2026
- Earnings
- Nov 3, 2026
- 50-d avg
- 20.64
- 200-d avg
- 18.11
- 1y target
- 24.84
2Y chart
Events in this range
- Jun 5, 2025Dividend: 0.0618
- Aug 5, 2025Earnings: 0.12; estimate 0.11; surprise 9.09%
- Nov 6, 2025Earnings: 0.16; estimate 0.14; surprise 14.29%
- Dec 2, 2025Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Mar 4, 2026Earnings: 0.21; estimate 0.2; surprise 5%
- Mar 5, 2026Rating: Keybanc · Overweight → Overweight
- Mar 5, 2026Rating: Citigroup · Buy → Buy
- Mar 6, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- May 7, 2026Earnings: 0.13; estimate 0.12; surprise 8.33%
- Jun 11, 2026Dividend: 0.0622
- Jun 16, 2026Rating: TD Cowen · — → Buy
- Aug 4, 2026Earnings: 0.16; estimate 0.1448; surprise 10.5%
- Sep 9, 2026Rating: UBS · Neutral → Neutral
Signals (96)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 10, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| RSI: Overbought | Aug 20, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 4, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 21, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| SMA: Bearish | Jul 15, 2026 | 3 months ago |
| SMA: Bullish | Jul 7, 2026 | 3 months ago |
| SMA: Bullish | Jun 30, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 30, 2026 | 4 months ago |
| SMA: Bearish | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 29, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 25, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 17, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| RSI: Overbought | Apr 30, 2026 | 6 months ago |
| SMA: Bullish | Apr 16, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 8, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 24, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 11, 2026 | 8 months ago |
| RSI: Oversold | Jan 23, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 16, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 24, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 9, 2025 | 10 months ago |
| SMA: Bearish | Dec 4, 2025 | 11 months ago |
| SMA: Bullish | Dec 3, 2025 | 11 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 28, 2025 | 11 months ago |
| SMA: Bearish | Nov 26, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| RSI: Oversold | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 31, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 31, 2025 | 1 year ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 21, 2025 | 1 year ago |
| SMA: Bullish | Oct 17, 2025 | 1 year ago |
| SMA: Bearish | Oct 9, 2025 | 1 year ago |
| SMA: Bullish | Oct 8, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 25, 2025 | 1 year ago |
| SMA: Bullish | Sep 5, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 28, 2025 | 1 year ago |
| SMA: Bullish | Aug 27, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| SMA: Bearish | Aug 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 24, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 18, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 24, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 20, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 10, 2025 | 1 year ago |
| SMA: Bullish | Jun 4, 2025 | 1 year ago |
| SMA: Bearish | Jun 3, 2025 | 1 year ago |
| MACD: Sell Signal | May 23, 2025 | 1 year ago |
| MACD: Buy Signal | May 8, 2025 | 1 year ago |
| SMA: Bullish | May 2, 2025 | 1 year ago |
| SMA: Bearish | May 1, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 29, 2025 | 1 year ago |
| SMA: Bullish | Apr 11, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 11, 2025 | 1 year ago |
| SMA: Bearish | Apr 3, 2025 | 1 year ago |
| SMA: Bullish | Apr 2, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 28, 2025 | 1 year ago |
| SMA: Bearish | Mar 26, 2025 | 1 year ago |
| SMA: Bullish | Mar 18, 2025 | 1 year ago |
| SMA: Bearish | Mar 11, 2025 | 1 year ago |
| SMA: Bullish | Mar 7, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 7, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 27, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 10, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 10, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 6, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 5, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 4, 2025 | 1 year ago |
| SMA: Bullish | Jan 29, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 14, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 2, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 24, 2024 | 1 year ago |
| RSI: Overbought | Dec 12, 2024 | 1 year ago |
Key statistics
- Market cap
- 5.28B
- Enterprise value
- 5.89B
- Trailing P/E
- 33.91
- Forward P/E
- 23.42
- PEG ratio
- 1.44
- Price / sales
- 4.31
- Price / book
- 3.03
- EPS (TTM)
- 0.57
- Beta
- 0.78
- Dividend yield
- 0.30%
- Payout ratio
- 11.02%
- Profit margin
- 10.99%
- Revenue (TTM)
- 1.23B
- Revenue growth
- 7.80%
- Free cash flow
- -104.70M
- Total cash
- 79.14M
- Total debt
- 445.30M
- Return on equity
- 9.13%
- Shares outstanding
- 49.71M
- Short % of float
- 1.97%
- 50-day average
- 20.64
- 200-day average
- 18.11
Analyst view
Consensus: buy
Buy
Price target (mean) 24.84 +28.2% upside
Now 19.38
- Target (low)
- 21.00
- Target (mean)
- 24.84
- Target (high)
- 32.00
Ratings (0m) 13 9 buy · 4 hold · 0 sell
- Strong buy2
- Buy7
- Hold4
- Sell0
- Strong sell0
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate 0.1776.
Financials — quick view
STVN Revenue — quarterly 302.00M
STVN Net income — quarterly 22.96M
STVN EPS — quarterly 0.08
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Sep 30, 2026 | 0.1775 | — | — | — |
| Aug 4, 2026 | Jun 30, 2026 | 0.1448 | 0.16 | +0.02 | +10.50% |
| May 7, 2026 | Mar 31, 2026 | 0.12 | 0.13 | +0.01 | +8.33% |
| Mar 4, 2026 | Dec 31, 2025 | 0.20 | 0.21 | +0.01 | +5.00% |
| Nov 6, 2025 | Sep 30, 2025 | 0.14 | 0.16 | +0.02 | +14.29% |
| Aug 5, 2025 | Jun 30, 2025 | 0.11 | 0.12 | +0.01 | +9.09% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 9, 2026 | UBS | main | Neutral | Neutral |
| Jun 16, 2026 | TD Cowen | init | — | Buy |
| Mar 6, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Mar 5, 2026 | Citigroup | main | Buy | Buy |
| Mar 5, 2026 | Keybanc | main | Overweight | Overweight |
| Dec 2, 2025 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
About Stevanato Group S.p.A.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Italy
- Website
- stevanatogroup.com
News
- Conestoga Small Cap Composite Q3 2026 Portfolio Activity
- Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System Selection
- Riverwater Partners Sustainable Value Strategy Q3 2026 Portfolio Update
- Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026
- Stevanato Group S.p.A. (STVN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- UBS Maintains Neutral on Stevanato Group, Lowers Price Target to $23
- Stevanato Group to Participate in Two Upcoming Investor Conferences
- A Look at Stevanato Group SpA (STVN) After 3.4% Decline -- GF Value $25.98 vs Price $20.71
- Stevanato Group: Alina Validates The Container-To-Device Flywheel
- Stevanato Group SpA (STVN) Shares Fall 5.7% -- What GF Score of 87 Tells Investors
Your note
Sign in to keep a note on STVN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BALACHANDRAN MADHAVEN | Director | Sale | Jun 14, 2026 | 69,458 |
| DAL LAGO MARCO | Chief Financial Officer | Sale | Aug 6, 2026 | 81,144 |
| FEDERICI WILLIAM J | Director | Sale | Jun 14, 2026 | 58,580 |
| FLYNN KAREN A | Director | Sale | Jun 14, 2026 | 5,757 |
| LIN SUE-JEAN | Director | Stock Award(Grant) | Jun 11, 2026 | 6,975 |
| MAGISTRETTI ELISABETTA | Director | Sale | Aug 6, 2026 | 2,930 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Conestoga Capital Advisors, LLC | 2.31% | 7,007,613 | 135.46M | Jun 29, 2026 |
| Neuberger Berman Group, LLC | 1.86% | 5,622,269 | 108.68M | Jun 29, 2026 |
| Times Square Capital Management, LLC | 1.15% | 3,474,641 | 67.16M | Jun 29, 2026 |
| Van Berkom & Associates Inc. | 0.98% | 2,969,220 | 57.40M | Jun 29, 2026 |
| Artisan Partners Limited Partnership | 0.86% | 2,601,598 | 50.29M | Jun 29, 2026 |
| BAMCO Inc. | 0.82% | 2,494,871 | 48.23M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Conestoga Funds-Conestoga Small Cap Fund | 1.15% | 3,484,751 | 67.36M | Jun 29, 2026 |
| NEUBERGER BERMAN EQUITY FUNDS-Neuberger Genesis Fund | 1.00% | 3,041,141 | 58.79M | Sep 29, 2026 |
| BARON INVESTMENT Fd.S TRT -BARON DISCOVERY Fd. | 0.56% | 1,681,429 | 32.50M | Jun 29, 2026 |
| Artisan Partners Funds Inc.-Artisan Small Cap Fund | 0.28% | 837,773 | 16.19M | Jun 29, 2026 |
| AMG Funds-AMG TimesSquare Mid Cap Growth Fund | 0.22% | 653,137 | 12.63M | Jun 29, 2026 |
| Conestoga Funds-Conestoga SMid Cap Fund | 0.20% | 596,192 | 11.52M | Jun 29, 2026 |